Search Results for “FDA” – Page 163 – media

GlaxoSmithKline Invests $300 Million in 23andMe

23andMe declared an investment of $300 million on Wednesday, made by GlaxoSmithKline to attain special access to their DNA database.
- Source: HealthcareIT News
- 578
- July 27, 2018
Company Insight genetic testing GSK
New Blood Test Replaces Costly CT Scan to Detect Head Injury

Around 54 million to 60 million people throughout the world are annually surviving with Traumatic Brain Injury annually. CT scan tests of the head are the common diagnostic choices in such cases. This extensive use of CT scans leads to unnecessary radiation exposure with high costs.
- Source: News Medical
- 688
- July 27, 2018
blood test CT scanner head injury Researches
Boy’s Skin becomes hard as stone –Stiff Skin Syndrome

Stiff skin syndrome causes a person's skin to harden and thicken across the entire body. This thickening results in a person being unable to move his or her joints, leaving the joints stuck in a bent position. The genetic disorder affects the protein named fibrillin-1, which allows the elastic fibers in the skin to stretch.
- Source: LiveScience
- 636
- July 27, 2018
autoimmune Researches skin problems
Merck Presents 96-Week Doravirine HIV Data Three Months before PDUFA Date

96-week data on doravirine, Merck’s HIV drug, was posted by the drugmaker recently. Merck expects it to outrun drugs like Bristol-Myers Squibb’s Sustiva in combination regimens and antiretroviral drugs from AbbVie and Johnson & Johnson in viral suppression.
- Source: FierceBiotech
- 890
- July 27, 2018
HIV Merck Researches
Bayer Announces the end of Essure Sales in the US

Bayer announced on last Friday that it would stop the sales of its Essure birth control system in the United States by the end of this year due to a steady decline in its sales making the product no longer justifiable. Bayer insisted that its decision to discontinue Essure sales is only for business reasons and not for any safety or efficacy concerns.
- Source: MDDI Online
- 637
- July 25, 2018
Company Insight contraceptive device FDA
AbbVie Investors Need not Abandon Ship yet

After watching Scott Gottlieb, M.D. of the FDA comments regarding the rebate rule changes and a warning tweet on biosimilars, AbbVie investors are bailing out. But the industry watchers claim that they don’t need to be.
- Source: FiercePharma
- 1,078
- July 24, 2018
AbbVie biopharmaceutical FDA Market Views
Viz.ai Develops AI Software to Detect Stroke

Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
- Source: FierceBiotech
- 815
- July 20, 2018
AI Company Insight digital health FDA
Genetic Disorder Cured in Utero Using Gene-Editing Technique

In what seems to be a first of its kind research, Carnegie Mellon University and Yale University researchers have successfully cured a genetic condition in a mouse model with a gene editing technique. The findings of the study showcase a potential new opportunity for further research into treating genetic disorders in utero.
- Source: drugdu
- 474
- July 19, 2018
gene editing Researches
Electrocore Releases Gammacore Therapy against Migraine and Episodic Cluster Headaches

ElectroCore, famous for bioelectronic medicines, is associating with UpScriptHealth to deliver its gammaCore treatment via direct-to-patient telemedicine program. This non-invasive stimulation therapy of vagus nerve is used to treat migraines and episodic cluster headaches among the adults.
- Source: FierceBiotech
- 761
- July 19, 2018
biotech cluster headache medtech migraine New Approvals
Recent Study Reports on Liver Cancer Risks and Detection

HCC or hepatocellular carcinoma can result in patients getting liver diseases such as viral hepatitis and non-alcoholic fatty liver disease with cirrhosis due to disease progression. New data from recent researches shows factors that improve early detection and diagnosis, and risks prior to HCC and during treatment.
- Source: Healio
- 560
- July 19, 2018
liver cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.